Data protection Impressum

Financing

Vaud-based life sciences company Limula has secured CHF 6.2 million to democratize access to life-saving cell and gene therapies.

Limula secures CHF 6.2 million to advance automated cell therapy platform

21 May 2024

Yuon Control successfully closed a first financing round to accelerate market adoption of their innovative and predictive heating control software to optimize heating networks.

Yuon Control secures funding to boost innovation in the heating sector

14 May 2024

Bernese start-up Green-Y Energy has successfully closed a CHF 3 million investment round to advance the market launch of its innovative compressed air energy storage system.

CHF 3 million for Green-Y Energy’s compressed air energy storage solution

14 May 2024

Geneva-based digital private bank Alpian has successfully closed its Series C funding round, securing a total of CHF 76 million to accelerate its growth and enhance its digital wealth management services.

Digital bank Alpian secures CHF 76 million to drive growth and innovation

14 May 2024

Ikerian AG, along with its subsidiary RetinAI, has successfully completed a USD 6.18 million Series A extension financing round to propel the development and commercial rollout of innovative medical technologies.

Ikerian, parent company of RetinAI, secures USD 6.18 million for AI-driven medical advancements

13 May 2024

Testmate Health, a Lausanne-based start-up, has successfully raised USD 6 million to advance the development and commercialization of their at-home rapid test kits for sexually transmitted infections (STIs).

Testmate Health raises USD 6 million to combat STIs with innovative home testing kits

8 May 2024

Bernese medtech machineMD and Oxford-based gaitQ have jointly received a million-dollar research grant from InnovateUK and Innosuisse, aimed at enhancing the monitoring and early detection of Parkinson's disease.

machineMD and gaitQ awarded grant for Parkinson’s research in the UK and Switzerland

7 May 2024

EP Equity Investment (EPEI), a company dedicated to investing in promising European companies, has acquired a 24.99% stake in Nanobacterie to advance the development of innovative treatments for prostate cancer.

Nanobacterie secures strategic investment from EP Equity to advance prostate cancer treatment

6 May 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2024)

30 April 2024

NovaMea, a cleantech start-up from the EPFL, has raised USD 3.2 million to advance the research and development of its green hydrogen production technology.

NovaMea secures USD 3.2 million to boost green hydrogen production

30 April 2024

1 … 9 10 11 12 13 14 15 16 17 … 33